Halozyme Announces FDA Approval of Tecentriq Hybreza™ With ENHANZE® for Various Cancers
Pharma Focus Asia
by
3d ago
Halozyme Therapeutics Inc has confirmed that Roche has received approval from the US Food and Drug Administration FDA for Tecentriq Hybreza atezolizumab and hyaluronidasetqjs incorporating Halozymes ENHANZE drug delivery technology ..read more
Visit website
Vironexis Biotherapeutics Secures FDA Clearance for First AAV-delivered Cancer Immunotherapy Trial
Pharma Focus Asia
by
3d ago
Vironexis Biotherapeutics has officially launched unveiling its TransJoin AAV Gene Therapy Platform which focuses on transforming cancer treatment through AAVdelivered Tcell immunotherapy Vironexiss innovative TransJoin platform enables a patients body to express an engineered transgene directing T ..read more
Visit website
Sanofi Enter into Agreement with RadioMedix and Orano Med for Next-Generation Radioligand Therapy to Treat Rare Cancers
Pharma Focus Asia
by
3d ago
Sanofi has entered into an exclusive licensing agreement with RadioMedix and Orano Med a French biotechnology subsidiary of Orano Group to advance the development of AlphaMedix As part of the agreement Sanofi will take responsibility for the global commercialisation of AlphaMedix while Orano Med wil ..read more
Visit website
Mobile Tech in Clinical Trials
Pharma Focus Asia
by
3d ago
Innovent Biologics Inca worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncology autoimmune cardiovascular and metabolic ophthalmology and other major diseases announced the presentation of Phase clinical data ..read more
Visit website
Hyundai Bioscience announces XAFTY®, a groundbreaking broad-spectrum antiviral capable of treating COVID-19, mpox, and dengue
Pharma Focus Asia
by
3d ago
Dr HeungJeong Woo a vice president of Hyundai Bioscience shared insights on the current state of antiviral treatments at the Disease Prevention and Control Summit He highlighted the lack of effective therapies for global public health threats like COVID dengue mpox HIVAIDS and influenza type A HN a ..read more
Visit website
GC Cell and PT Bifarma Adiluhung sign a licensing agreement for Immuncell-LC to expand access in Ind
Pharma Focus Asia
by
3d ago
GC Cell a leading innovator in cell therapy has officially announced the execution of a landmark Technology Transfer and License Agreement with PT Bifarma Adiluhung Bifarma a premier stem cell therapy company in Indonesia This strategic partnership which began in June solidifies approximately three ..read more
Visit website
NTU Singapore and Oxford study discover new process for cells to repair DNA damage
Pharma Focus Asia
by
3d ago
A team of international researchers at the University of Oxford Oxford and Nanyang Technological University Singapore NTU Singapore has discovered a new process for repairing damaged DNA that is particularly relevant for patients undergoing colorectal cancer treatments ..read more
Visit website
Ono and Bristol-Myers Squibb KK Submit Supplemental Application of Opdivo and Yervoy in Combination Treatment in Japan to Expand the Use for Unresectable Advanced or Recurrent Microsatellite
Pharma Focus Asia
by
3d ago
Ono Pharmaceutical Co Ltdand BristolMyers Squibb KK today announced the submission of supplemental application of Onos antiPD antibody Opdivo generic name nivolumab Intravenous Infusion Opdivo and BMSKKs antiCTLA antibody Yervoy Injection Yervoy in combination therapy in Japan to expand the use for ..read more
Visit website
Telisotuzumab Vedotin (Teliso-V) Developed for the Treatment of Non-Small Cell Lung Cancer
Pharma Focus Asia
by
1w ago
SummaryBiocontamination refers to biological contamination of products by bacteria andor fungi as well as the toxic byproducts of these microorganisms such as endotoxin and mycotoxins from Gramnegative bacteria and fungi respectively When designing a biocontamination control strategy which is based on the manufacturing process there are three componen ..read more
Visit website
Real-world Evidence
Pharma Focus Asia
by
3w ago
Grace Liu Technical Account Manager at Sino Biological US Inc walks us through antibodydrug conjugate ADC development highlighting their structure the ..read more
Visit website

Follow Pharma Focus Asia on FeedSpot

Continue with Google
Continue with Apple
OR